| scholarly article | Q13442814 |
| P50 | author | Patrick Romano | Q42712150 |
| P2093 | author name string | J Kim | |
| R H White | |||
| H Zhou | |||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2033-2041 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism | |
| P478 | volume | 160 |
| Q36953357 | A Population-Based Study of Inferior Vena Cava Filters in Patients With Acute Venous Thromboembolism |
| Q35535961 | British Thoracic Society guidelines for the management of suspected acute pulmonary embolism |
| Q41375903 | Case report on the non-operative management of a retrievable inferior vena cava filter perforating the duodenum |
| Q37748594 | Catheter-directed thrombolysis of lower limb thrombosis |
| Q38149914 | Clinical review: inferior vena cava filters in the age of patient-centered outcomes |
| Q33436975 | Controversies in the management of cancer-associated thrombosis |
| Q28194897 | DVT prophylaxis and anticoagulation in the surgical patient |
| Q81584045 | Deep vein thrombosis |
| Q35122966 | Diagnosis and treatment of pulmonary embolism in the elderly |
| Q34441615 | Duration of anticoagulation for venous thromboembolism |
| Q35103057 | Duration of therapy for acute venous thromboembolism |
| Q36619908 | Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome |
| Q41511421 | Economic burden of recurrent venous thromboembolism: analysis from a U.S. hospital perspective |
| Q34376129 | Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy |
| Q33590496 | Five-year follow-up of pulmonary embolism under anticoaugulation: The PISA-PEET (Pulmonary Embolism Extension Therapy) study |
| Q51155511 | Guidelines on use of vena cava filters. |
| Q35525678 | Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study |
| Q39467332 | Hospital Variation and Patient Characteristics Associated With Vena Cava Filter Utilization |
| Q97520328 | Inferior vena cava filter - comprehensive overview of current indications, techniques, complications and retrieval rates |
| Q36876016 | Inferior vena cava filters for recurrent thrombosis: current evidence |
| Q46039945 | Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE): patterns of use and outcomes. |
| Q37924506 | Inferior vena cava filters: a concise review |
| Q34462703 | Inferior vena cava filters: current best practices |
| Q37806831 | Interventional Therapies for Venous Thromboembolism: Vena Caval Interruption, Surgical Embolectomy, and Catheter-Directed Interventions |
| Q83663365 | Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial |
| Q61451089 | Long-Term Clinical Outcomes of Complicated Retrievable Inferior Vena Cava Filter for Deep Venous Thrombosis Patients: Safety and Effectiveness |
| Q79686128 | Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians |
| Q36988467 | Optional vena cava filters: what, why, and when |
| Q55303987 | Patient and hospital characteristics predictive of inferior vena cava filter usage in venous thromboembolism patients: A study from the 2013 to 2014 Nationwide Readmissions Database. |
| Q46034366 | Perforation of the IVC: rule rather than exception after longer indwelling times for the Günther Tulip and Celect retrievable filters. |
| Q34441624 | Perioperative management of the chronically anticoagulated patient |
| Q79954098 | Pulmonary embolism |
| Q34196135 | Pulmonary embolism in the elderly |
| Q26826847 | Recurrent venous thromboembolism: what is the risk and how to prevent it |
| Q34153343 | Risk assessment for recurrent venous thrombosis |
| Q40416627 | Temporary Vena Caval Interruption and Thrombolysis in the Management of Deep Vein Thrombosis |
| Q88590274 | The use of inferior vena cava filters in spine trauma: A nationwide study using the National Trauma Data Bank |
| Q36395168 | Therapy Insight: management of urology patients taking long-term warfarin anticoagulation therapy |
| Q35081863 | Thromboprophylaxis and thrombosis in medical, surgical, trauma, and obstetric/gynecologic patients |
| Q35595796 | Treatment and management of acute venous thromboembolic disease |
| Q33401715 | Treatment of established thrombotic events in patients with cancer |
| Q37642825 | Update on perioperative bridging in patients on chronic oral anticoagulation. |
| Q47862004 | Update on vena cava filters |
| Q33357532 | Value of a long duration temporary caval filter in critical thrombo-embolic situations |
| Q33727966 | Variation in the Use of Vena Cava Filters for Venous Thromboembolism in Hospitals in Kentucky. |
| Q42373749 | Vena Cava Filter Retrieval Rates and Factors Associated With Retrieval in a Large US Cohort |
| Q79285403 | Vena cava filters: risks and advantages |
| Q35800317 | Vena caval filters: a review for intensive care specialists |
| Q26741697 | Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants |
| Q42948654 | Warfarin therapy in patients with venous thromboembolism: Patterns of use and predictors of clinical outcomes |
| Q80025006 | [Inferior vena cava filter update] |
| Q82598470 | [Removal of retrievable inferior vena cava filters 90 days after implantation in an ovine model: is there a time limit for removal?] |
| Q82993848 | [Thromboprophylaxis in patients with previous thromboembolic disease who require major orthopedic surgery] |
| Q84807043 | [Vena cava filters in trauma patients] |
Search more.